- MyopiaX-1 trial to generate first clinical evidence with MyopiaX®, a novel therapeutic approach to manage myopia progression- First data readout expected.
“Everyone has noticed that it seems like the kids are becoming nearsighted faster than they used to,” says Dr. Grace Prakalapakorn at the Duke Eye Center.
“Everyone has noticed that it seems like the kids are becoming nearsighted faster than they used to,” says Dr. Grace Prakalapakorn at the Duke Eye Center.
Kubota Vision Announces Collaborative Research Agreement with China Medical University Hsinchu Hospital streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
SEATTLE (BUSINESS WIRE) Kubota Vision Inc. (“Kubota Vision” or the “Company”), a clinical-stage specialty ophthalmology company and a wholly owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today the execution of a collaborative research agreement between Kubota Vision and China.